PALO ALTO, Calif.–(BUSINESS WIRE)–Transcripta Bio, an AI-powered drug discovery company focused on neurological and neuromuscular diseases, today announced a know-how agreement with Mayo Clinic focused on the molecular characterization of autism spectrum disorder (ASD). The collaboration seeks to combine Mayo Clinic’s clinical genomics and neurodevelopmental expertise with Transcripta Bio’s transcriptomic drug discovery platform to investigate the molecular mechanisms underlying ASD and ident
